EUVIMEDEUVIMED entdecken
Metaanalyse

Clinical Outcomes and Prognostication of CRTC1::TRIM11 Fusion Cutaneous Tumors

Nithya S Trichy, Jonathan Braat, Lindsay J Holic, Shantel Olivares, Klaus J Busam, Alison Cheah, Jeffrey M Cloutier, Damian Collins, Pranav Dorwal, Arnaud de la Fouchardière, John Gross, Eleni Ieremia und 10 weitere

American Journal of Surgical Pathology · 2026-09 · 50 (9) · 1015-1028

DOI: 10.1097/pas.0000000000002575 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift American Journal of Surgical Pathology, online erschienen am 03.06.2026. Verfasst von Nithya S Trichy und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL. Hauptthemen laut MEDLINE: Skin Neoplasms, Biomarkers, Tumor, Transcription Factors, Gene Fusion. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the original description of CRTC1::TRIM11 fusion cutaneous tumors (CTCT) in 2018, an increasing number of cases with metastatic behavior have been reported, yet there are limited studies analyzing prognostic parameters. This expanding data set presents an opportunity for reappraisal of clinical behavior. We present a series of 21 cases with detailed morphologic, molecular, clinical outcomes, and therapeutic response data. We utilize this data and a meta-analysis of all the cases in the literature to assess potential prognostic parameters to assist in clinical management. Primary tumors resulting in metastasis were larger ( P =0.038), had higher mitotic counts ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsBiomarkers, TumorTranscription FactorsGene FusionHumansFemaleMiddle AgedMaleAgedAdultTreatment OutcomeAged, 80 and overMutationPhenotypePrognosisPromoter Regions, GeneticTelomerase

Stichwörter der Autor:innen

CRTC1::TRIM11CTCTcutaneous tumormelanomamesenchymal tumor

Substanzen

Biomarkers, TumorTranscription FactorsTERT protein, humanTelomerase

Autor:innen und Institutionen

  • Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
  • Department of Pathology, Dermatopathology Service, Memorial Sloan Kettering Cancer Center.
  • Department of Anatomical Pathology, Douglass Hanly Moir Pathology, Macquarie Park.
  • Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH.
  • Department of Cellular Pathology, Queen Elizabeth Hospital.
  • Department of Pathology, Monash Health.

Zitieren

APA

Trichy, N. S., Braat, J., Holic, L. J., Olivares, S., Busam, K. J., Cheah, A., Cloutier, J. M., Collins, D., Dorwal, P., de la Fouchardière, A., Gross, J., Ieremia, E., John, I., Karunamurthy, A., Linos, K., Moshiri, A. S., Salinas, J. A., Shalin, S., Stewart, C., …, & Gerami, P. (2026). Clinical Outcomes and Prognostication of CRTC1::TRIM11 Fusion Cutaneous Tumors. American Journal of Surgical Pathology, 50(9), 1015-1028. https://doi.org/10.1097/pas.0000000000002575

Vancouver

Trichy NS, Braat J, Holic LJ, Olivares S, Busam KJ, Cheah A, et al. Clinical Outcomes and Prognostication of CRTC1::TRIM11 Fusion Cutaneous Tumors. American Journal of Surgical Pathology. 2026;50(9):1015-1028. doi:10.1097/pas.0000000000002575

BibTeX
@article{Trichy2026,
  author = {Trichy, Nithya S and Braat, Jonathan and Holic, Lindsay J and Olivares, Shantel and Busam, Klaus J and Cheah, Alison and Cloutier, Jeffrey M and Collins, Damian and Dorwal, Pranav and de la Fouchardière, Arnaud and Gross, John and Ieremia, Eleni and John, Ivy and Karunamurthy, Arivarasan and Linos, Konstantinos and Moshiri, Ata S and Salinas, José A and Shalin, Sara and Stewart, Campbell and Thway, Khin and Weston, Gillian and Gerami, Pedram},
  title = {Clinical Outcomes and Prognostication of CRTC1::TRIM11 Fusion Cutaneous Tumors},
  journal = {American Journal of Surgical Pathology},
  year = {2026},
  volume = {50},
  number = {9},
  pages = {1015--1028},
  doi = {10.1097/pas.0000000000002575}
}
Kostenlos starten →